Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences (Pharmacology), College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA.
Int J Mol Sci. 2020 Jan 16;21(2):574. doi: 10.3390/ijms21020574.
Aldosterone is produced by adrenocortical zona glomerulosa (AZG) cells in response to angiotensin II (AngII) acting through its type I receptors (ATRs). ATR is a G protein-coupled receptor (GPCR) that induces aldosterone via both G proteins and the adapter protein βarrestin1, which binds the receptor following its phosphorylation by GPCR-kinases (GRKs) to initiate G protein-independent signaling. β-adrenergic receptors (ARs) also induce aldosterone production in AZG cells. Herein, we investigated whether GRK2 or GRK5, the two major adrenal GRKs, is involved in the catecholaminergic regulation of AngII-dependent aldosterone production. In human AZG (H295R) cells in vitro, the βAR agonist isoproterenol significantly augmented both AngII-dependent aldosterone secretion and synthesis, as measured by the steroidogenic acute regulatory (StAR) protein and CYP11B2 (aldosterone synthase) mRNA inductions. Importantly, GRK2, but not GRK5, was indispensable for the βAR-mediated enhancement of aldosterone in response to AngII. Specifically, GRK2 inhibition with Cmpd101 abolished isoproterenol's effects on AngII-induced aldosterone synthesis/secretion, whereas the GRK5 knockout via CRISPR/Cas9 had no effect. It is worth noting that these findings were confirmed in vivo, since rats overexpressing GRK2, but not GRK5, in their adrenals had elevated circulating aldosterone levels compared to the control animals. However, treatment with the β-blocker propranolol prevented hyperaldosteronism in the adrenal GRK2-overexpressing rats. In conclusion, GRK2 mediates a βAR-ATR signaling crosstalk in the adrenal cortex leading to elevated aldosterone production. This suggests that adrenal GRK2 may be a molecular link connecting the sympathetic nervous and renin-angiotensin systems at the level of the adrenal cortex and that its inhibition might be therapeutically advantageous in hyperaldosteronism-related conditions.
醛固酮由肾上腺皮质球状带(zona glomerulosa,AZG)细胞产生,以响应血管紧张素 II(Angiotensin II,AngII)通过其 I 型受体(type I receptor,ATR)发挥作用。ATR 是一种 G 蛋白偶联受体(G protein-coupled receptor,GPCR),它通过 G 蛋白和衔接蛋白β-arrestin1 诱导醛固酮的产生,后者在 GPCR 激酶(GPCR-kinases,GRKs)磷酸化受体后与受体结合,从而启动 G 蛋白非依赖性信号转导。β-肾上腺素能受体(β-adrenergic receptor,βAR)也可诱导 AZG 细胞产生醛固酮。在此,我们研究了两种主要的肾上腺 GRK,即 GRK2 和 GRK5,是否参与儿茶酚胺对 AngII 依赖性醛固酮产生的调节。在体外人 AZG(H295R)细胞中,βAR 激动剂异丙肾上腺素显著增强了 AngII 依赖性醛固酮分泌和合成,这可通过类固醇急性调节蛋白(steroidogenic acute regulatory protein,StAR)蛋白和 CYP11B2(醛固酮合酶)mRNA 诱导来衡量。重要的是,GRK2 而非 GRK5 对于βAR 介导的 AngII 反应性醛固酮增强是必不可少的。具体而言,用 Cmpd101 抑制 GRK2 消除了异丙肾上腺素对 AngII 诱导的醛固酮合成/分泌的作用,而通过 CRISPR/Cas9 敲除 GRK5 则没有影响。值得注意的是,这些发现得到了体内的证实,因为在其肾上腺中过表达 GRK2 而非 GRK5 的大鼠与对照动物相比,循环醛固酮水平升高。然而,用β-阻断剂普萘洛尔治疗可预防肾上腺 GRK2 过表达大鼠的高醛固酮血症。总之,GRK2 介导了肾上腺皮质中的βAR-ATR 信号转导串扰,导致醛固酮产生增加。这表明肾上腺 GRK2 可能是连接交感神经系统和肾素-血管紧张素系统的分子联系,其抑制在与高醛固酮血症相关的情况下可能具有治疗优势。